Filing Flows › Arcadia Biosciences (RKDA) › Q2 2026 › vs Q1 2026
Arcadia Biosciences (RKDA) Q2 2026 vs Q1 2026 (quarter over quarter)
Arcadia Biosciences's revenue rose $343K (+31%) from $1.1M in Q1 2026 to $1.4M in Q2 2026.
Arcadia Biosciences, Q2 2026: revenue $1.4M (-0.8% year over year), operating margin -34.4%, net loss $6.3M, operating cash flow −$319K. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $1.4M | $1.1M | $343K | +31% |
| Net loss | $6.3M | $4.4M | $1.9M | +43% |
| Costs & expenses | $7.7M | $5.5M | $2.2M | +41% |
| Operating costs | $1.9M | $1.9M | $60K | +3% |
| Interest & other, net | $5.8M | $3.6M | $2.2M | +60% |
| Cost of revenue | $812K | $700K | $112K | +16% |
| SG&A | $1.1M | $1.2M | −$52K | -4% |
| Operating cash sources | $6.3M | $4.4M | $1.9M | +43% |
| Share-based compensation | $14K | $15K | −$1K | -7% |
| Working capital & other | $5.9M | $3.3M | $2.7M | +82% |
| Cash used in operations | $319K | $1.1M | −$780K | -71% |
| Net loss absorbed | $6.3M | $4.4M | $1.9M | +43% |
Questions
How much did Arcadia Biosciences's revenue grow quarter over quarter in Q2 2026?
Arcadia Biosciences's revenue rose $343K (+31%) from $1.1M in Q1 2026 to $1.4M in Q2 2026.